Featured Research

from universities, journals, and other organizations

Pilot program to decrease emergency room wait times

Date:
June 11, 2013
Source:
University of California, San Diego Health Sciences
Summary:
Emergency department overcrowding has been a major issue nationally for 20 years and continues to increase in severity. To address this issue, a pilot study has been launched at UC San Diego Health System’s ED to use telemedicine as a way to help address crowding and decrease patient wait times. The study is the first of its kind in California to use cameras to bring on-call doctors who are outside of the hospital to the patient in need.

Emergency department (ED) overcrowding has been a major issue nationally for 20 years and continues to increase in severity. To address this issue, a pilot study has been launched at UC San Diego Health System's ED to use telemedicine as a way to help address crowding and decrease patient wait times. The study is the first of its kind in California to use cameras to bring on-call doctors who are outside of the hospital to the patient in need.

"This telemedicine study will determine if we can decrease wait times while reducing the number of patients who leave the ED without being seen by a physician," said David Guss, MD, principal investigator and chair of the department of emergency medicine at UC San Diego School of Medicine. "With the ED physicians on site and an added telemedicine physician, patient care may be significantly expedited. If the use of a telemedicine evaluation can be shown to be safe and effective, it may shift how care in the emergency department is delivered."

The study, called Emergency Department Telemedicine Initiative to Rapidly Accommodate in Times of Emergency (EDTITRATE), brings telemedicine doctors to patients when the ED becomes busy. An offsite doctor is paged who then remotely links to a telemedicine station to see patients. With the aide of an ED nurse, these patients are seen based on arrival time and level of medical need. All patients must sign a consent form to participate in the study.

Guided by high fidelity sound and video, the telemedicine physician can examine a patient's eyes, ears, nose, throat and skin, as well as listen to heart and lung sounds through the module. Laboratory and imaging tests can be ordered and results reviewed. Physician ordering and documentation is accomplished through an electronic medical record. As a final step, the onsite attending physician reassesses the patient to confirm findings and actions, as well as address any unanswered patient questions.

"Working in an emergency department opened around the clock, you never know who may come through the door, so you are constantly faced with the challenge of matching staffing resources with the demands for care," said Guss. "Some emergency departments have placed a physician in the triage area to expedite care, however, if there is low demand for service during these times, an underutilized physician creates an unneeded expense."

To add to the challenge, when an on call physician is needed to augment provider resource, there can be delays in making the call or significant delay until the physician arrives. With a telemedicine doctor, the wait is just minutes.

"ED overcrowding increases patient risk and decreases patient satisfaction with emergency services," said Vaishal Tolia, MD, MPH, FACEP, emergency medicine physician at UC San Diego Health System. "Implementing telemedicine in the emergency department setting may improve the overall experience for both patients and medical staff."

Six rooms in the Hillcrest ED can currently accommodate the telemedicine module, and the project can be activated during the busiest times, Monday through Friday.

The study is supported by a $50,000 University of California Health Quality Improvement (CHQI) grant awarded to Tolia this year.

"We will continue to use the CHQI grant to enhance the efficiency of the project and train staff," said Guss. "Our goal is to eventually expand this project to our emergency department in La Jolla, and if the study proves successful, potentially see it deployed in other hospital emergency departments across the nation."


Story Source:

The above story is based on materials provided by University of California, San Diego Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of California, San Diego Health Sciences. "Pilot program to decrease emergency room wait times." ScienceDaily. ScienceDaily, 11 June 2013. <www.sciencedaily.com/releases/2013/06/130611130915.htm>.
University of California, San Diego Health Sciences. (2013, June 11). Pilot program to decrease emergency room wait times. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/06/130611130915.htm
University of California, San Diego Health Sciences. "Pilot program to decrease emergency room wait times." ScienceDaily. www.sciencedaily.com/releases/2013/06/130611130915.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins